Pulmonary arterial hypertension antibody therapeutic (Diagonal Therapeutics)

N/A

Report date: 2024/04/22 17:41:26

Base Information

Drug NamePulmonary arterial hypertension antibody therapeutic (Diagonal Therapeutics)
Drug Alias NameAgonist Antibody for Pulmonary Arterial Hypertension (PAH) (Diagonal Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiagonal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDiagonal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A